Mei Song
- Epidemiology top 1%
- Hepatology top 0.5%
- Molecular Biology top 10%
- Oncology top 2%
- Immunology top 5%
- Topics
- Liver Disease Diagnosis and Treatment (10 papers)MicroRNA in disease regulation (9 papers)Cancer-related molecular mechanisms research (9 papers)
- Cited by
- HepatologyEpidemiologyOncology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Mei Song
72 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Epidemiology 1.9k
- Hepatology 1.4k
- Molecular Biology 1.2k
- Oncology 1.1k
- Immunology 644
Countries citing papers authored by Mei Song
This map shows the geographic impact of Mei Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Song more than expected).
Fields of papers citing papers by Mei Song
This network shows the impact of papers produced by Mei Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Song. The network helps show where Mei Song may publish in the future.
Co-authorship network of co-authors of Mei Song
This figure shows the co-authorship network connecting the top 25 collaborators of Mei Song. A scholar is included among the top collaborators of Mei Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Song. Mei Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 23 | |
| 6 | 35 | |
| 7 | 33 | |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 9 | |
| 11 | 111 | |
| 12 | 20 | |
| 13 | 0 | |
| 14 | 2 | |
| 15 | Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivobreakdown → | 628 |
| 16 | 86 | |
| 17 | 153 | |
| 18 | FDI's real impact on foreign exchange reserves: Evidence from China | 3 |
| 19 | 37 | |
| 20 | 6 |
About Mei Song
Mei Song is a scholar working on Hepatology, Cancer Research and Health Informatics, having authored 76 papers that have together received 4.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (1.9k citations) and Oncology (1.1k citations). Mei Song has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhiyi Jing, Wenhui Li, Wenhui He, Guangwei Xu, B Ren, Yonghe Qi, Huan Yan, Guocai Zhong, Jianhua Sui and Xiaozhong Peng. Their work appears in journals such as Nature Communications, Nature Biotechnology and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.